FDA Drug recall D-0704-2017
Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street,…
- FDA Drug
- Class III
- terminated
- Published 2017-05-17
On 2017-05-17 the FDA classified a Class III recall of Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street,… by Sanofi Aventis U S, citing labeling: Incorrect or Missing Package Insert.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0704-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-09-01 |
| Published | 2017-05-17 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Sanofi Aventis U S |
| Distribution | n/a |
Product
Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01
Reason
Labeling: Incorrect or Missing Package Insert
Identifiers
| ndc | 0024-5862-01 |
|---|---|
| code_info | Lot #: 5RZ001C, 5RZ001D; Exp. 04/18 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0704-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.